SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high...read more
Category - Industry news
Fabric Genomics Launches GEM Algorithm to Accelerate Genetic Disease Diagnosis, Provide Comprehensive Clinical-Decision Support
Fabric GEM’s accuracy validated across five leading genomics centers of excellence in the U.S. and abroad OAKLAND, Calif.–(BUSINESS WIRE)–Fabric Genomics, a global leader in clinical interpretation of...read more
PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care
Multiple targeted assays from Pillar Biosciences to be combined with the PierianDx platform to reduce time, cost, and complexity of clinical genomic testing St. LOUIS, MO. and NATICK, MA., OCTOBER 14, 2020 —PierianDx...read more
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
— World-class germline and somatic testing, liquid biopsy and tissue genomic profiling, now delivered from a single platform with unrivaled breadth and flexibility — SAN FRANCISCO, Oct. 5, 2020 /PRNewswire/...read more
